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Regulation of protein translation constitutes a crucial step in control of gene 
expression. In comparison to transcriptional regulation, however, translational 
control has remained a significantly under-studied layer of gene expression. This 
trend is now beginning to shift thanks to recent advances in next-generation 
sequencing, proteomics, and microscopy based methodologies which allow 
accurate monitoring of protein translation rates, from single target messenger RNA 
molecules to genome-wide scale studies. In this review, we summarize these recent 
advances, and discuss how they are enabling researchers to study translational 
regulation in a wide variety of in vitro and in vivo biological systems, with 
unprecedented depth and spatiotemporal resolution. 
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Introduction 
The central dogma of molecular biology states that genetic information flows sequentially 
from DNA, via messenger RNA (mRNA), to proteins, the often final functional products of 
gene expression1. As a result of decades of intense research in both prokaryotes and 
eukaryotes, it is mechanistically well understood how DNA is transcribed and processed 
into mRNA, and how mRNA is translated into proteins. However, a key issue remaining is 
how the rates of information flow - from genes to proteins - are regulated, and how the 
protein levels are defined inside the cell at any given time. As transcription initiates the 
cascade of genetic information flow, it had long been assumed to be the defining step in 
regulation of gene expression. Thanks to a variety of global transcriptome analysis 
methods such as DNA micro-array chip hybridization (micro-array)2 and RNA-
sequencing (RNA-seq)3, much has been revealed regarding regulation of gene 
expression at the mRNA level. In addition, Chromatin Immunoprecipitation (ChIP) 
followed by micro-array chip hybridization (ChIP-chip)4 or next-generation sequencing 
(ChIP-seq)5 methods have enabled analysis of transcription factor-DNA associations on 
genome-wide scales. This has brought about system level understanding of transcriptional 
networks and their regulation in a wide variety of biological systems, and in response to 
various physiological or pathological modulations. However, little is known about how gene 
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expression at the level of translation is regulated. Ironically, multitude of studies using 
quantitative proteomics in conjugation with transcriptomics have highlighted that globally 
little correlation exists between mRNA and protein levels in various biological systems6-11, 
although individual protein/mRNA ratio levels seem to be conserved12, 13. This suggests 
that the bulk of gene expression regulation must occur post-transcriptionally. Crucially, with 
the advent of methods that allow measurement of protein translation rates on a global 
scale, it has become apparent that translational control seems to be the defining step in 
determining the steady-state levels of most cellular proteins14, 15. Consequently, the 
interest in studying the impacts of translational regulation has greatly surged in recent 
years. This has been matched by development of a plethora of diverse methodologies 
which allow assessment of protein translation in vitro and in vivo, and from the scale of 
individual target mRNAs all the way to genome-wide studies. In this review, we compare 
and contrast these methods and their applications, and discuss how they can be used to 
reveal the dynamics of translational regulation (Table 1). We also discuss how these 
methods can be utilized to spatially resolve the sites of protein translation inside the cell, 
and implication of such spatial information on our understanding of the role and 
significance of localized translation in cell biology. 
Next-generation sequencing based analysis of translation: 
As initiation is often the rate-limiting step in regulation of protein translation, association of 
mRNAs with translating ribosomes can be used as a proxy for estimation of translation 
rates (Table 1). Ribosome association with mRNAs can be monitored by purifying 
polysomes through sedimentation in a sucrose gradient, and assessing relative mRNA 
enrichment levels in the polysomal fraction by micro-array or next-generation sequencing 
analysis, a method known as polysome profiling16. Despite its robust methodology, 
however, polysome profiling suffers from a number of drawbacks. Simply equating the co-
sedimentation of an mRNA with polysomes to its translation is rather a crude assumption, 
as several other large Ribonucleoprotein (RNP) complexes can co-sediment with 
polysomes17. Moreover, polysome profiling does not take into account the well-known fact 
that apart from the major Open Reading Frame (ORF), additional ORFs in the 5’ UTR of 
mRNAs that are known as upstream ORFs (uORF) exist in around half of all cellular 
transcripts, which can be independently undergoing translation18. Ribosome profiling 
(ribo-seq), mitigates these shortcomings by enabling position sensitive assessment of 
translation on a genome-wide scale15. In this method, translation is first halted through 
rapid detergent-based lysis, flash-freezing, or use of ribosome translocation inhibitors such 
as cycloheximide. The mRNA-ribosome complexes are then purified by sedimentation and 
subjected to nuclease treatment, leaving 20-30 nucleotide long ribosome protected mRNA 
fragments known as ribosome foot-prints. These footprints can be accurately identified and 
quantified with single nucleotide resolution, using RNA-seq19 (Figure 1A).  
The single nucleotide resolution of ribo-seq enables the exact sequence identity of all 
translating ORFs to be systematically revealed on a genome-wide scale. Consequently, 
ribosome profiling studies have been able to reveal widespread translation occurring 
outside of canonical ORFs. These include translation from alternative initiation sites, use 
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of non-AUG start codons, overlapping ORFs, and stop codon bypasses20-24. In addition, 
widespread translation can also be mapped to uORFs, as well as other short ORFs 
(sORF) which reside in RNAs that were previously thought to be non-coding20, 23, 25-28. 
Apart from revealing non-canonical ORFs, a key feature of ribo-seq is its ability to capture 
an instantaneous snapshot of the translatome. This, combined with the extreme sensitivity 
and the broad dynamic range that can be achieved with next-generation sequencing, 
renders ribo-seq an ideal method for sensitive in-depth quantification of temporal changes 
in the translatome29-32. In addition, as an alternative to sedimentation, translating 
ribosomes can be purified by immunoprecipitation of epitope tagged ribosomal proteins, a 
method known as translating ribosome affinity purification-sequencing (TRAP-seq) 
33. Such epitope tagged ribosomal proteins can be transgenically expressed in specific
cell-types of a given model organism, thus enabling ribosome profiling to be applied for
monitoring of cell-specific translation, in vivo34 (Figure 1B).
Ribo-seq can also be adapted for spatial analysis of translation. This can either be done 
by using subcellular fractionation prior to purifying ribosomes35, or through use of 
proximity-specific ribosome profiling36, 37. In the latter, rather than using an epitope tag, 
ribosomal proteins are tagged with a biotin acceptor peptide (Avi Tag). In parallel, a 
biotin ligase (BirA) is targeted to a specific subcellular compartment. A carefully 
optimized biotin pulse can then result in specific biotinylation of ribosomes in the vicinity of 
localized BirA. Labeled ribosomes are then purified via streptavidin conjugated resins for 
ribo-seq analysis36, 37 (Figure 1C). Proximity-specific ribosome profiling is particularly 
useful for assessment of localized translation in subcellular compartments which cannot 
be separated via available cell fractionation methods, or in case available fractionation 
procedures perturb the subcellular distribution of ribosomes that are associated with a 
given compartment. 
Despite its great advantages, however, ribo-seq suffers from a number of drawbacks. A 
key assumption in ribo-seq analysis is the uniformity of translation elongation rates 
amongst all cellular mRNAs15. While this is thought to be true in most cases, some RNA 
Binding Proteins (RBPs) such as FMRP have been shown to regulate the translation of 
their target mRNAs by stalling the elongating ribosomes throughout the full lengths of the 
ORF38. Such regulations at the level of elongation could be misinterpreted when using ribo-
seq. Another major limitation of ribo-seq is the needed amounts of starting material. This 
is due to the fact that at any given time point, only a small fraction of total cellular mRNAs 
tends to be associated with ribosomes. Furthermore, as with any biochemical purification 
step, efficient separation of ribosomes by sedimentation or TRAP depends on ample 
amounts of input material. A final drawback is the large number of steps in the sample 
preparation and analysis pipeline, which makes ribo-seq experiments costly, time-
consuming, and prone to potential experimental artefacts.  
Proteomics based analysis of translation: 
In contrast to ribo-seq which evaluates the association of mRNAs with ribosomes as a 
proxy for protein synthesis, proteomics based methods which have been developed for 
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assessment of translation do so by direct identification and quantification of nascent 
proteins. This is achieved by labeling nascent proteins through pulses of amino acid 
isotopologues, non-canonical amino acids, or specific chemical conjugates, followed by 
purification and quantification of the pulse-labeled proteins via mass spectrometry (Table 
1). Pulsed-SILAC (p-SILAC)39 is one such method, based on Stable Isotope Labeling 
of Amino acids in Culture (SILAC)40. P-SILAC utilizes pulse treatments of stable 
isotopologues of arginine (Arg) and lysine (Lys), in order to metabolically label newly 
synthesized proteins at time points defined by the pulse (Figure 2A). Initially, cells are 
cultured in presence of unlabeled ‘light’ Arg and Lys. Culture media are then changed to 
media containing ‘medium’ (Arg6 and Lys4) or ‘heavy’ (Arg10 and Lys8) labeled SILAC 
amino acids for the duration of the pulse. After samples are harvested, mixed, and 
processed, peptides are analyzed by Liquid Chromatography coupled with tandem 
Mass Spectrometry (LC-MS/MS), and newly synthesized proteins containing labeled 
amino acids are identified and quantified39 (Figure 2A). This approach has been 
fundamental in determining the translation rates of cellular proteins in mammalian cell 
cultures, and systematically assessing the contribution of protein translation towards 
determining the steady-state levels of cellular proteins14. Moreover, as p-SILAC requires 
minimal sample processing and does not depend on any biochemical purification step after 
lysis, it enables assessment of protein translation rates from relatively small sample sizes. 
This has allowed combining p-SILAC with subcellular fractionation in order to determine 
the localized translation rates of cellular proteins from even small subcellular fractions41. 
However, a significant shortcoming of p-SILAC is its relative low coverage due to the low 
abundance of labeled peptides after short pulse times. In addition, detectable labeling can 
only be achieved in timescale of hours rather than minutes, thus limiting the temporal 
resolution of p-SILAC for analyses of translation dynamics. This is because pulsed amino 
acids need to be first taken up by the cells and conjugated to transfer RNA (tRNA), before 
being incorporated into nascent proteins in detectable quantities, a process that is far from 
instantaneous. Finally, although SILAC has been utilized in vivo through generation of 
isotopically labeled whole organisms42, p-SILAC has not been extended to in vivo analysis 
yet. Efficient pulse-labeling with SILAC amino acids in vivo will be challenging due to the 
large pool of unlabeled amino acids present. Achieving cell-specificity is also challenging, 
although it may be possible to employ cell type specific labeling with amino acid 
precursors (CTAP) to overcome this issue43, 44. In CTAP, a set of non-native amino acid 
biosynthesis enzymes are utilized to generate isotope labeled Lys residues from unnatural 
isotope labeled amino acid precursors. These enzymes can be expressed in a cell-type 
specific manner, thus enabling cell-specificity in SILAC labeling of Lys residues in co-
cultures45. However, it remains to be determined whether CTAP can be combined with 
pulse-labeling in order to assess translation rates in a cell-specific manner. 
In contrast to p-SILAC which uses stable isotopologues, bio-orthogonal non-canonical 
amino acid tagging (BONCAT)46 utilizes pulses of non-canonical amino acids for labeling 
of nascent proteins (Figure 2B). Critical to this method is the fact that certain non-canonical 
amino acids such as azidohomoalanine (Aha), a methionine analogue that contains an 
active azide moiety, can be incorporated into proteins in the position of their canonical 
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counterpart, due to the permissive nature of certain amino acyl-tRNA synthetases. After 
incorporation, these amino acids can be either coupled to fluorescent compounds, or to 
affinity tags such as biotin, via Click chemistry47. The former method is known as 
fluorescent non-canonical amino acid tagging (FUNCAT), and allows overall 
visualization of nascent proteins in vitro and in vivo48, 49. In the latter, biotin labeled nascent 
proteins are purified from the total protein pool, followed by their identification and 
quantification via LC-MS/MS46. Biotin enables purification under stringent conditions, thus 
limiting non-specific pulldown of any un-labeled proteins. Crucially, use of BONCAT amino 
acids does not interfere with synthesis of proteins in vitro46 and in vivo49, 50. However, the 
affinities of most cellular amino acyl-tRNA synthetases to non-canonical amino acids are 
often significantly less than those of their canonical counterpart, which significantly 
reduces the efficiency of BONCAT labeling in presence of their canonical counterparts. 
This is a major limiting factor for use BONCAT in vivo where cognate canonical amino acid 
pools cannot be concomitantly removed. Moreover, BONCAT labeling is not cell-type 
specific on its own, further limiting the usefulness of the method for in vivo analysis of 
translation. 
To counter these issues, bacterial amino acyl-tRNA synthetases have been engineered to 
have a higher affinity for given non-canonical amino acids, and to conjugate such amino 
acids to specific mammalian tRNAs51. These engineered synthetases can be 
transgenically expressed in a given cell-type, thus allowing cell-specific BONCAT labeling 
in vivo52, 53. A related approach named stochastic orthogonal recoding of translation 
(SORT) relies on genetic code expansion, achieved via co-expression of an orthogonal 
amino acyl-tRNA synthetase/tRNA pair in specific cells. The pyrrolysyl-tRNA synthetase 
(PylRS)/tRNA-CUA pair is particularly useful, since it can be engineered to accept a wide 
range of useful unnatural amino acids with diverse chemical side chains. This allows cell-
specific incorporation of unnatural amino acids into proteins at specific codons, using 
various sense codon sequences. SORT has been utilized to specifically label newly 
synthesized proteins at different tissues and stages of D. melanogaster larval development 
54, and to enrich SORT-tagged proteins for pull-down assays55.  
Similar to p-SILAC, a major shortcoming of methods which use non-canonical amino acids 
for analysis of translation, is their low temporal resolution. Another weakness is 
compromised quantitative accuracy. Pull-down efficiency of nascent proteins is affected 
by the number and sites of incorporated non-canonical amino acids, as well as the inherent 
protein-dependent variations in the click chemistry. Moreover, label-free quantification of 
nascent protein levels across different pull-down samples requires multiple replicates and 
is only semi-quantitative. These issues are not pertinent to p-SILAC, since labeling 
efficiency is uniform. In addition, samples that are pulsed with different SILAC amino acids 
are mixed together when the lysates are generated, which eliminates any variability caused 
by sample handling, and allows highly accurate relative quantification of labeled peptides 
within a mixed sample pair. To overcome the quantitative constrains of BONCAT, 
quantitative non-canonical amino acid tagging (QuaNCAT) combines p-SILAC and 
BONCAT in the experimental workflow (Figure 2C)56. Briefly, cells are pulsed with both 
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BONCAT and SILAC amino acids. The lysates are then mixed and nascent proteins are 
purified via click chemistry, followed by their identification and quantification by mass 
spectrometry using the SILAC labeled peptides. QuaNCAT allows accurate relative 
quantification thanks to the SILAC labels. However, unlike standard p-SILAC, QuaNCAT 
can achieve a higher proteome coverage due to the enrichment the low-abundant pulse-
labeled proteins56. Dual pulsing and enrichment can also improve the temporal resolution, 
by enabling detection of nascent proteins from shorter pulse times57, 58. More recently, 
another method termed Heavy Isotope Labeled Azidohomoalanine Quantification 
(HILAQ) has been developed, in which light and heavy isotope labeled Aha variants are 
utilized for both tagging and quantification of nascent proteins59. As opposed to BONCAT 
and QuaNCAT, in which Click dependent biotin labeling and enrichment is performed at 
the protein level, in HILAQ the pre-mixed heavy and light Aha pulse-labeled lysates are 
first trypsin digested, and Click dependent biotin labeling and enrichment is then performed 
at the peptide level. This allows specific enrichment of Aha containing peptides for mass 
spectrometry identification and quantification. Thus, while HILAQ is truly quantitative like 
QuaNCAT, the use of isotope labeled Aha does away with the need for double SILAC-
BONCAT labeling and greatly simplifies the experimental workflow59.   
An alternative method for labeling of nascent proteins is the antibiotic puromycin. 
Puromycin, produced by the bacterium Streptomyces, is an aminonucleoside antibiotic 
which inhibits translation elongation in both prokaryotic and eukaryotic cells. The broad 
specificity of puromycin renders it unsuitable for therapeutic use, and it is therefore 
exclusively used for research purposes. The chemical structure of puromycin shows strong 
similarity to that of an amino acyl-tRNA molecule. More precisely, puromycin closely 
resembles the 3' terminal end of a tyrosyl-tRNA conjugate60, 61. This attribute gives 
puromycin the ability to occupy the acceptor site of the ribosome during translation 
elongation, and become incorporated into the nascent polypeptide chain in a non-selective 
manner, thanks to the action of ribosome peptidyl-transferase. However, once 
puromycinylated, the peptidyl chain cannot receive any further amino acids, leading to 
premature termination of translation, and the eventual falling off of the puromycinylated 
peptide from the traversing ribosome.  
In mammalian cells, puromycin can robustly inhibit translation in the timescale of minutes 
and at low micro-molar concentrations60, 61. Importantly, unlike BONCAT or SILAC amino 
acids, pulsed puromycin is rapidly incorporated into translating poly-peptides, allowing fast 
labeling of nascent proteins. Such puromycin labeled nascent proteins can be visualized 
via microscopy, or detected by western-blotting or fluorescence-activated cell sorting 
(FACS), using an anti-puromycin antibody62. Alternatively, Puromycin-associated 
nascent chain proteomics (PUNCH-P) utilizes a biotinylated variant of puromycin (Biotin-
PURO) for global profiling of nascent proteins by LC-MS/MS63. In PUNCH-P, the 
polysomes are first isolated by sedimentation, followed by labeling of nascent proteins with 
Biotin-PURO during cell-free translation. Labeled nascent proteins are then purified by 
streptavidin conjugated beads, and identified by LC-MS/MS, providing an instantaneous 
snapshot of cellular translation rates at the time of lysis (Figure 2D). Labeling under cell-
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free conditions is crucial due to the low cell permeability of Biotin-PURO. This is a major 
disadvantage for PUNCH-P, as prior lysis and sedimentation of ribosome will result in loss 
of any spatial regulation that may be influencing the cellular translation rates in live cells. 
However, since long puromycin incubation times can be performed in cell-free conditions 
as opposed to live cells, PUNCH-P can achieve a high proteome coverage thanks to 
accumulating large quantities of puromycylated proteins 63. 
Another variant of puromycin used for global translation monitoring is O-propargyl-
puromycin (OPP)64. OPP contains an alkyne group, which through Click chemistry can 
be covalently coupled to fluorescent tags for visualization of nascent proteins, or to biotin 
for their capture and identification by LC-MS/MS64. As opposed to biotin-PURO, OPP is 
cell permeable, thus enabling the labeling of nascent proteins to be performed in live cells 
(Figure 2D). Moreover, a newly designed OPP analogue which carries a phenylacetyl 
group (PhAc-OPP), allows labeling to be achieved in a cell-specific manner65. Owing to 
the added phenylacetyl group, PhAc-OPP is rendered inactive. However, orthogonal 
expression of the enzyme penicillin G acylase (PGA), which can remove the phenylacetyl 
group, leads to generation of active OPP in the enzyme expressing cells, thus allowing 
labeling and subsequent profiling of nascent proteins in a cell-specific manner. Transgenic 
expression of PGA in specific cell-types of a model organism, could therefore enable cell-
specific monitoring of translation rates in vivo, using otherwise harmless pulses of PhAc-
OPP.  
Thanks to the rapid incorporation of puromycin into nascent proteins, puromycin based 
methods discussed above can at least in theory achieve far better temporal resolutions 
compared to p-SILAC and BONCAT. However, as mentioned for BONCAT, label-free 
quantification of nascent protein levels across different captured samples is only semi-
quantitative. Although it remains to be demonstrated, combining puromycin based labeling 
methods with mass spectrometry quantification techniques such SILAC40 or tandem mass 
tagging (TMT)66, should overcome this issue in future. 
Live cell imaging of translation: 
The next-generation sequencing and proteomics methods discussed above enable global 
assessment of protein translation rates, but at discrete time points. Thanks to a number of 
recently developed live cell imaging methodologies, it is now also possible to continuously 
monitor translation of specific mRNAs in real-time (Table 1). Translating RNA imaging 
by coat protein knock-off (TRICK) allows live imaging of the first round of translation 
from single mRNA molecules, in both cultured cells and model organisms67. TRICK utilizes 
a two-color fluorescent microscopy technique to label a target mRNA after its 
transcription68. Briefly, a stretch of specific RNA hairpin repeats is added to the 3’UTR of 
the mRNA. Each hairpin can bind to an exogenous RBP such as the MS2 bacteriophage 
coat protein (MCP). Expression of a Red Fluorescent Protein (RFP) tagged MCP allows 
visualization of the target mRNAs in the red fluorescent channel. Importantly, due to the 
amplification of the fluorescent signal as a result of multiple hairpin repeats, even single 
mRNA molecules can be detected above the background noise levels. A nuclear 
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localization signal (NLS) is also added to the RFP-MCP in order to enrich it in the 
nucleus, thus enabling the immediate coating of the target mRNA molecules after 
transcription. In parallel, a distinct stretch of RNA hairpin repeats, which is similarly 
recognized by another exogenous RBP, such as the PP7 bacteriophage coat protein 
(PCP), is added to the same target mRNA but within the ORF region. Expression of a 
Green Fluorescent Protein (GFP) tagged PCP bearing an NLS allows concomitant 
detection of the mRNA molecules in the green fluorescent channel. Crucially, prior to the 
pioneer round of translation, an mRNA molecule is visible in both red and green channels, 
thus appearing as a yellow spot in the live imaging feed. However, during the first round of 
translation, the moving ribosome knocks the GFP-PCP molecules off the mRNA ORF 
region, resulting in loss of green fluorescence, thus the change of color from yellow to red 
in the live image feed (Figure 3A). TRICK is a powerful method for visualization of 
translation initiation at the single molecule level. Nevertheless, it does not inform on the 
actual rates of protein translation, as it cannot reveal the level of ribosome association with 
a target mRNA molecule. 
Recently, four independent studies reported similar methods for direct visualization of 
protein translation in live cells, using a combined mRNA and protein fluorescent tagging 
approach69-73. These methods, nicknamed nascent chain tracking (NCT), or single-
molecule imaging of nascent peptides (SINAPS), allow continuous monitoring of 
translation dynamics through visualization of nascent polypeptide chains that are 
associated with their cognate mRNA molecules69-73. In all methods, the target mRNA is 
tagged and visualized at the single molecule level with a 3’UTR RNA hairpin repeat that is 
recognized by a fluorescently tagged exogenous RBP. In parallel, the coded protein is N-
terminally tagged by multiple epitope repeats which can be recognized at the single 
molecule level by an intracellular fluorescent antibody. Key to this approach is the use of 
epitope tags as opposed to direct tagging with conventional fluorescent proteins such as 
GFP and RFP74. Fluorescent proteins have long maturation times, which means they 
cannot be utilized for instantaneous visualization of nascent proteins. Use of epitope tags 
allows nascent proteins to be rapidly detected with pre-expressed intracellular fluorescent 
antibodies as they exit the translating ribosomes. Co-localization of these detectable 
nascent chains with their cognate mRNA molecule is indicative of active translation, and 
their fluorescence intensity acts as an indicator of the amount of translation that is 
occurring from a single mRNA molecule, at a given time (Figure 3B)69-73.  
Although not a global approach, NCT/SINAPS is an extremely powerful methodology for 
targeted live cell monitoring of translation initiation, elongation, and termination, over long 
periods of time (>1 hr)69-73. But perhaps the greatest advantage of NCT/SINAPS is its 
ability to assess the spatiotemporal dynamics of translation at the single molecule level, 
thus revealing the intra-cellular as well as inter-cellular heterogeneity in translational 
control, a feat that is not possible via next-generation sequencing or proteomics based 
global methods which report population averaged translation rates. Crucially, although 
NCT/SINAPS has not been adapted for in vivo use yet, this should be possible in the near 
future through genome editing of endogenous alleles in a cell specific manner, thus 
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enabling live spatiotemporal assessment of translation dynamics in more physiological 
contexts. 
Table 1. List of methods for analysis of translation in time and space. 
Method Advantages Disadvantages Ref 
Polysome 
profiling 
Reproducible; quantitative; high depth of 
analysis; gives an instantaneous snapshot of 
the translatome (high temporal resolution). 
Contamination by co-sedimented RNPs can be an 
issue; does not reveal the exact ORF sites in an 
mRNA; more association of an mRNA to ribosomes 
may not always mean more translation.  
16
 Ribo-seq High depth of analysis; single-nucleotide 
resolution; allows de novo ORF detection; 
highly quantitative; gives an instantaneous 
snapshot of the translatome (high temporal 
resolution). 
Costly and time consuming; requires a large amount 
of starting material; more association of an mRNA to 
ribosomes may not always mean more translation. 
15, 20
 TRAP-seq Similar to ribo-seq but can be used for cell-
specific in vivo analysis of translation.   
Similar to ribo-seq, but requires more starting 
material. 
33, 34
Proximity-
specific 
ribo-seq 
Similar to ribo-seq but can reveal subcellularly 
localized translation. 
Similar to TRAP-seq, but requires even more starting 
material as only a fraction of total cellular ribosomes 
are labeled and purified. 
36, 37
P-SILAC Quantitative; measures nascent proteins; 
allows analyses from small sample sizes and 
subcellular compartments. 
Low depth; limited temporal resolution due to the 
need for incorporation of pulsed amino acids into 
cellular proteins; cannot be readily used in in vivo. 
14, 39, 
41
BONCAT Measures nascent proteins; higher depth than 
p-SILAC due to enrichment of nascent 
proteins. 
Limited temporal resolution due to the need for 
incorporation of pulsed amino acids into cellular 
proteins; cannot be readily used in vivo without 
utilizing engineered amino acyl-tRNA synthetases; 
semi-quantitative. 
46
SORT Similar to BONCAT but can be used for cell-
specific in vivo analysis of translation. 
Generation of animal models costly and time 
consuming. Limited temporal resolution due to the 
need for incorporation of pulsed amino acids into 
cellular proteins; semi-quantitative. 
54
QuaNCAT Quantitative like p-SILAC, but at higher depths 
due to enrichment of nascent proteins; 
improved temporal resolution in comparison to 
BONCAT and p-SILAC; measures nascent 
proteins. 
Improved, but still limited temporal resolution due to 
the need for amino acid pulsing; cannot be readily 
used in in vivo. 
56
HILAQ Quantitative like p-SILAC, but at higher 
depths; Experimental workflow much simpler 
that QuaNCAT; Improved depth and temporal 
resolution in comparison to QuaNCAT. 
Improved, but still limited temporal resolution due to 
the need for amino acid pulsing; cannot be readily 
used in in vivo. 
59
PUNCH-P High depths of analysis; gives an 
instantaneous snapshot of the translatome 
(high temporal resolution); measures nascent 
proteins. 
Time consuming; requires prior lysis and purification 
of translating ribosomes, thus losing any spatial 
regulatory influences on translation; requires a large 
amount of starting material; semi-quantitative. 
63
OPP 
capture 
Improved temporal resolution compared to p-
SILAC and BONCAT due to rapid OPP 
incorporation into cellular proteins; measures 
nascent proteins; can be used for cell-specific 
in vivo assessment of translation (PhAc-OPP). 
Semi-quantitative (as of now). 64, 65
 TRICK Allows live monitoring the first round of 
translation; single molecule sensitivity; can 
potentially be used in vivo. 
Not high throughput; low signal to noise ratio; cannot 
be used for assessment of translation rates, but only 
visualizing the pioneer round of translation. 
67
 NCT/ 
SINAPS 
Allows continuous monitoring of translation 
dynamics in live cells over time scales of 
hours; single molecule sensitivity; reveals 
translation heterogeneity; can potentially be 
used in vivo.  
Not high-throughput; background fluorescent 
accumulation over time can be an issue.  
69-72
Discussion 
Compared to our substantial understanding of transcriptional networks and their 
regulation, knowledge of translational regulation in different biological processes is still in 
its infancy. Thanks to several newly developed methods, however, this imbalance is 
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beginning to be redressed. As summarized in this review, these methods employ diverse 
technologies from next-generation sequencing and proteomics to single-molecule live cell 
fluorescent imaging, in order to enable researchers to map and measure protein 
translation, in vitro and in vivo. As these methods become more readily available to 
different researchers, it is likely that multiple approaches will be used in combination for a 
more comprehensive assessment of translational regulation. For instance, ribo-seq can be 
used as a pioneering experiment, defining the translatome of a given cell. This can then 
be followed by proteomics approaches such as p-SILAC or BONCAT for rapid assessment 
of changes in translation rates of different ORFs, across multiple cell states or treatments, 
using a tailored reference protein sequence database derived from the ribo-seq data, for 
all subsequent proteomics searches75-77.  
Crucially, despite the here discussed recent advances in monitoring protein translation, 
several technological hurdles still remain to be overcome. For instance, ribosome profiling 
studies have revealed a significant degree of translation occurring outside of the canonical 
ORFs. However, detection of these non-canonical, often short, ORFs at the protein level 
have been extremely challenging due to their low abundance78. Further advances in mass 
spectrometry, namely more sensitive and faster instrumentations, are required to enable 
detection of these non-canonical ORFs at the protein level, paving the way for better 
assessment of their cellular functions. Moreover, a wealth of recent evidence indicates that 
many cellular mRNAs can undergo diverse RNA base modifications79. Many such 
modifications may affect protein translation, but this remains to be systematically 
demonstrated. Novel methods for global translation monitoring that are integrated with 
approaches which globally assess RNA modifications are needed in order to systematically 
interrogate the impact of different base modifications on translational regulation. Finally, 
while translation is often dysregulated in many pathological conditions such as neuronal 
disorders and cancers, the methodologies for assessment of protein translation have not 
been yet extended to clinical settings. It remains to be determined whether the available 
approaches can move beyond cells and model organisms and be adapted for assessment 
of translational dysregulation in clinical settings. 
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Figure 1. Next-generation sequencing based methods for global analysis of 
translation. (A) In ribo-seq, ribosome-bound mRNAs are purified by sedimentation 
following cell lysis. Nuclease treatment is then used to degrade unmasked RNA sections, 
leaving 20-30 nucleotide-long ribosome protected fragments known as ribosome 
footprints. The footprints are then subjected to library preparation and next-generation 
sequencing. (Below): the read densities can be used to both distinguish individual ORFs, 
as well as to quantify their translation rates, with a distinctive three-nucleotide periodic 
footprint pattern that is indicative of ribosome translocation often visible throughout the 
length of the ORF. (B) TRAP-seq differs from ribo-seq in the way ribosomes are purified. 
Rather than sedimentation, epitope tagged ribosomal proteins which are either stably 
expressed in cultured cells or transgenically in a given cell-type of an in vivo model, are 
subjected to immunoprecipitation in order to pulldown the translating ribosomes. Nuclease 
treatment is then used to degrade unmasked RNA sections, followed by library 
preparation, and next-generation sequencing of the footprints as before (below). (C) 
Proximity-specific ribo-seq allows assessment of subcellularly localized translation by 
tagging ribosomal proteins with a biotin acceptor peptide (Avi), coupled with expression of 
a subcellularly localized biotin ligase (BirA). A carefully optimized biotin pulse is then 
applied in order to induce biotinylation of the Avi tagged ribosomes in close proximity of 
the BirA. Subsequently, cells are lysed and biotinylated ribosomes are affinity purified 
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using streptavidin conjugated beads, followed by nuclease treatment, library preparation, 
and next-generation sequencing of the ribosome footprints as before (below).  
Figure 2. Proteomics based methods for global analysis of translation. (A) In p-
SILAC, the differences in protein synthesis rates are directly quantified by LC-MS/MS, 
through comparing the intensity ratios of SILAC pulsed labeled (K4/R6 vs. K8/R10) nascent 
proteins. Old, un-labeled (K0/R0) proteins are not taken into account during the data 
analysis. (B) In BONCAT, pulse-labeling is done by non-canonical amino acids such as 
the methionine analogue azidohomoalanine (Aha), which carries an active azide (N3) 
group. Using Click chemistry, pulse-labeled proteins can be covalently attached to an 
enrichment tag such as biotin, purified using streptavidin conjugated beads, before 
identification by LC-MS/MS. (C) QuaNCAT combines the principles of p-SILAC and 
BONCAT to metabolically label nascent proteins with both non-canonical and SILAC 
amino acids. QuaNCAT allows both enrichment of nascent proteins via non-canonical 
amino acid labeling, as well as accurate relative quantification through SILAC labeling. (D) 
Puromycin (PURO) based labeling methods use variants of the antibiotic puromycin for 
labeling and purification of nascent proteins. In PUNCH-P, cells are lysed and the 
translating ribosomes are separated by sedimentation, before cell-free labeling of the 
newly synthesized proteins, using a biotin-PURO conjugate. Alternatively, cells can be 
pulsed by an alkyne-puromycin conjugate called OPP, which unlike Biotin-PURO is cell 
permeable, followed by lysis and Click conjugation to biotin. In both methods, labeled 
nascent proteins are then purified using Streptavidin conjugated beads, and identified by 
LC-MS/MS. AA: amino acids; M: Methionine;  
Figure 3. Live cell imaging methods for targeted analysis of translation. (A) TRICK 
utilizes tagging of a target mRNA by two distinct stretches of hairpin repeats, each of which 
can be bound by a specific exogenous RBP (coat protein). The first repeat, recognized by 
a specific RFP tagged coat protein (red), is added after the stop codon (UGA), while the 
second repeat, recognized by a distinct GFP tagged coat protein (green), is added within 
the ORF. Before the pioneer round of translation, both types of coat proteins are bound to 
the mRNA molecule, resulting in it appearing as a yellow spot in the live image feed. 
However, during the first round of translation, the traversing ribosome displaces the GFP 
tagged coat proteins, resulting in a change of color from yellow to red in the live image 
feed. (B) NCT/SINAPS uses concurrent tagging of the target mRNA with a hairpin repeat, 
along with N-terminal tagging of its coded protein sequence with epitope repeats. Hairpin 
repeats are added after the stop codon, and recognized by an exogenous RFP tagged 
coat protein (red), which marks all individual mRNA molecules. As the newly synthesized 
epitopes (E) exit the ribosomes during translation, they are rapidly recognized by an 
intracellular GFP labeled antibody (green). This results in the translating mRNA molecule 
to change appearance from red to yellow in the live image feed. The co-localizing GFP 
fluorescent intensity can also be used to estimate translation rate dynamics of an individual 
mRNA molecule. Use of repeats allows fluorescent signal amplification that is needed for 
single-molecule visualization in both methods. 
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Glossary 
Amino acyl-tRNA synthetase: A family of enzymes which catalyze the covalent 
conjugation of specific amino acids to their corresponding tRNA molecules. 
Azidohomoalanine (Aha): An amino acid analogue of methionine which contains an azido 
moiety. 
Bio-orthogonal non-canonical amino acid tagging (BONCAT): A method for 
monitoring translation through pulse-labeling with non-canonical amino acids, followed by 
their affinity capture and LC-MS/MS analysis. 
Biotin acceptor peptide (Avi Tag): A 15 amino acid peptide sequence which can be 
recognized and biotinylated by the biotin ligase BirA. 
Biotin ligase (BirA): A biotin ligase enzyme, originally from E. coli, which is used to 
catalyze biotinylation of Avi tags. 
Cell type specific labeling with amino acid precursors (CTAP): A method for cell-
specific SILAC labeling of cells by non-mammalian amino acid precursor-processing 
enzymes to convert isotope labeled lysine precursors into labeled lysine in a given cell. 
Chromatin Immunoprecipitation (ChIP): An affinity purification method for purification of 
DNA segments attached to a specific protein. 
ChIP followed by micro-array chip hybridization (ChIP-chip): A method for systematic 
identification of DNA segments bound by a specific protein through micro-array analysis of 
ChIP samples. 
ChIP followed by next-generation sequencing (ChIP-seq): A method for systematic 
identification of DNA segments bound by a specific protein through next- generation 
sequencing analysis of ChIP samples. 
Click chemistry: A simple set of high yielding reactions based on azido and alkyne 
moieties that allow covalent conjugation of two or more molecules in a stereospecific 
manner. 
DNA micro-array chip hybridization (micro-array): A method for assessment of gene 
expression based on hybridization to a collection of microscopic DNA spots attached to a 
solid surface.  
Fluorescence-activated cell sorting (FACS): A flow cytometry method for sorting a 
heterogeneous mixture of fluorescently labeled cells, one cell at a time, based on their 
specific fluorescent properties. 
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Fluorescent non-canonical amino acid tagging (FUNCAT): A method for visualization 
of translation through pulse-labeling of nascent proteins with non-canonical amino acids, 
followed by their conjugation to fluorescent tags for microscopy analysis. 
Green Fluorescent Protein (GFP): A fluorescent protein derived from the jelly fish 
Aequorea victoria which exhibits green fluorescence when exposed to light in the blue to 
ultraviolet range. 
Heavy Isotope Labeled Azidohomoalanine Quantification (HILAQ): A modified version 
of BONCAT for quantitative monitoring translation, which utilizes pulse-labeling with 
isotope labeled Aha, followed by trypsin digestion, affinity capture of Aha containing 
peptides, and their relative quantification via LC-MS/MS analysis. 
Liquid Chromatography coupled with tandem Mass Spectrometry (LC-MS/MS): An 
analytical chemistry method which combines liquid chromatography with online tandem 
mass spectrometry, in order to resolve and analyze complex sample mixtures. 
Messenger RNA (mRNA): A family of cellular RNA which convey genetic information from 
DNA to the ribosomes for protein synthesis. 
MS2 bacteriophage coat protein (MCP): An RNA binding protein from the MS2 
bacteriophage, which is an icosahedral, single-stranded RNA virus that infects E. coli. 
Nascent chain tracking (NCT): A method for live cell imaging of translation which utilizes 
concurrent single molecule visualization of nascent proteins and their cognate mRNA. 
Nuclear localization signal (NLS): A stretch of positively charged amino acids that mark 
proteins for import into the nucleus by the nuclear transport machinery.  
Open Reading Frame (ORF): A stretch of codon sequences in an mRNA which do not 
contain a stop codon. 
O-propargyl-puromycin (OPP): A cell permeable variant of puromycin containing an
alkyne group.
Polysome profiling:  A global method for monitoring protein translation via micro-array or 
RNA-seq based quantification of polysome associated mRNAs. 
PP7 bacteriophage coat protein (PCP):  An RNA binding protein from the PP7 
bacteriophage, which is an icosahedral, single-stranded RNA virus that infects 
Pseudomonas aeruginosa. 
Proximity-specific ribosome profiling: A variant of ribo-seq which uses proximity-
specific biotinylation for tagging and separation of local ribosome associated mRNAs. 
Pulsed-SILAC (p-SILAC): A method for monitoring translation through pulse-labeling the 
cells with SILAC amino acids, followed by LC-MS/MS analysis. 
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Puromycin-associated nascent chain proteomics (PUNCH-P): A method for 
monitoring translation through pulse-labeling translating ribosomes with biotin-PURO in 
cell-free conditions, followed by the capture and analysis of labeled nascent proteins via 
LC-MS/MS. 
Quantitative non-canonical amino acid tagging (QuaNCAT): A method that combines 
p-SILAC and BONCAT through concurrent pulse-labeling with SILAC and BONCAT amino
acids, followed by their affinity capture and quantification via LC-MS/MS.
Red Fluorescent Protein (RFP): An engineered monomeric red fluorescent protein 
derived from the Discosoma sp. fluorescent protein ‘DsRed’. 
Ribonucleoprotein (RNP): A protein-RNA complex. 
Ribosome profiling (ribo-seq): A next-generation sequencing based method for 
assessment of translation through separation of translating ribosomes and sequencing of 
mRNA ribosome footprints. 
RNA Binding Protein (RBP): A protein which can bind to double or single stranded RNA 
molecules. 
RNA-sequencing (RNA-seq): A next-generation sequencing method for assessment of 
the sequence and quantity of RNA molecules in a biological sample. 
Stable Isotope Labeling of Amino acids in Culture (SILAC): A mass spectrometry 
based method for quantifying differences in protein abundance among different samples 
via non-radioactive isotopically labeled amino acids. 
Short ORFs (sORF): An ORF which is smaller than 300 nucleotide (100 amino acids). 
Single-molecule imaging of nascent peptides (SINAPS): A method for live cell imaging 
of translation which utilizes concurrent single molecule visualization of nascent proteins 
and their cognate mRNA. 
Stochastic orthogonal recoding of translation (SORT): A method for cell-specific 
monitoring of translation through ectopic expression of an orthogonal amino acyl-tRNA 
synthetase/tRNA pair, allowing cell-specific pulse-labeling with non-canonical amino acids 
at diverse sense codons. 
Transfer RNA (tRNA): A type of cellular RNA which functions by bringing amino acids to 
the ribosome during protein synthesis. 
Translatome: Collection of all proteins formed by translation of cellular mRNAs. 
Translating ribosome affinity purification-sequencing (TRAP-seq): A variant of ribo-
seq which uses Immunoprecipitation of tagged ribosomal proteins for separation of 
ribosome associated mRNAs. 
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Translating RNA imaging by coat protein knock-off (TRICK): A single molecule two-
color fluorescent live cell imaging method, in which mRNAs are constitutively detected in 
one fluorescent channel, but detection in the second channel is abrogated upon the first 
round of translation. 
Upstream ORFs (uORF): A small ORF which is situated within the 5'UTR of an mRNA. 
Un-Translated Region (UTR): A section of mRNA that is immediately situated upstream 
(5’) or downstream (3’) of an ORF.  
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